Targumic and Cognate Studies: Essays in Honour of Martin McNamara K. J. Cathcart M. Maher

Autor: Emerton, J. A.

Publikováno v: Vetus Testamentum, 1997 Jul 01. 47(3), 415-416.

Externí odkaz: https://www.jstor.org/stable/1535167

Randomized Phase III SIERRA Trial of ¹³¹ I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Autor: Gyurkocza B; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY., Nath R; Banner MD Anderson Cancer Center, Gilbert, AZ., Seropian S; Yale University School of Medicine-Yale Cancer Center, New Haven, CT., Choe H; The Ohio State University, Columbus, OH., Litzow MR; Mayo Clinic, Rochester, MN., Abboud C; Washington University School of Medicine, St Louis, MO., Koshy N; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX., Stiff P; Loyola University Medical Center, Maywood, IL., Tomlinson B; University Hospitals Cleveland Medical Center, Cleveland, OH., Abhyankar S; University of Kansas Cancer Center, Kansas City, KS., Foran J; Mayo Clinic, Jacksonville, FL., Hari P; Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI., Chen G; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; MD Anderson Cancer Center, Houston, TX., Al-Kadhimi Z; University of Nebraska Medical Center, Omaha, NE., Kebriaei P; MD Anderson Cancer Center, Houston, TX., Sabloff M; University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Orozco JJ; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Jamieson K; University of North Carolina (UNC), Chapel Hill, NC., Silverman M; University of Iowa, Iowa City, IA., Van Besien K; Weill Cornell Medical College, New York, NY., Schuster M; Stony Brook University Cancer Center, Stony Brook, NY., Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Larkin K; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH., Pandit-Taskar N; Department of Radiology, Memorial Sloan Kettering, New York, NY., Rowley SD; Hackensack University Medical Center, Hackensack, NJ., Munshi P; MedStar Georgetown University Hospital, Washington, DC., Cook R; Oregon Health & Science University, Portland, OR., Levy MY; Baylor Scott & White Health, Dallas, TX., Lazarus HM; Case Western Reserve University, Cleveland, OH., Sandmaier BM; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Pagel JM; Loxo Oncology at Lilly, Stamford, CT., Reddy V; D2V Clinical, Raleigh, Durham, NC., MacDougall J; Statistical Consultant to Actinium Pharmaceuticals, New York, NY., McNamara K; Actinium Pharmaceuticals, New York, NY., Spross J; Actinium Pharmaceuticals, New York, NY., Haeuber E; Actinium Pharmaceuticals, New York, NY., Vusirikala M; Actinium Pharmaceuticals, New York, NY., Nahar A; Actinium Pharmaceuticals, New York, NY., Desai A; Actinium Pharmaceuticals, New York, NY., Giralt S; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 19, pp. JCO2302018. Date of Electronic Publication: 2024 Sep 19.

Multimodal surface analyses of chemistry and structure of biominerals in rodent pineal gland concretions

Autor: Tofail, S.A.M., Mouras, R., McNamara, K., Patyk-Kazmierczak, E., Geaney, Hugh, Zaworotko, M., Ryan, Kevin M., Soulimane, T., Silien, C., Kopáni, M.

Publikováno v: In Applied Surface Science 1 March 2019 469:378-386

Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.

Autor: Grossman MK; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Rankin DA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Maloney M; Connecticut Department of Public Health, Hartford, Connecticut, USA., Stanton RA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gable P; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stevens VA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ewing T; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Saunders K; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Florida Department of Health, Tallahassee, Florida, USA., Kogut S; New York State Department of Health, Albany, New York, USA., Nazarian E; New York State Department of Health, Wadsworth Center, Albany, New York, USA., Bhaurla S; Los Angeles County Department of Public Health, Los Angeles, California, USA., Mephors J; Los Angeles County Department of Public Health, Los Angeles, California, USA., Mongillo J; Utah Department of Health and Human Services, Salt Lake City, Utah, USA., Stonehocker S; Davis County Health Department, Farmington, Utah, USA., Prignano J; Connecticut Department of Public Health, Hartford, Connecticut, USA., Valencia N; Florida Department of Health, Tallahassee, Florida, USA., Charles A; Florida Department of Health, Tallahassee, Florida, USA., McNamara K; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA., Fritsch WA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Ruelle S; Office of Regulatory Affairs, US Food and Drug Administration, Silver Spring, Maryland, USA., Plucinski CA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Sosa LE; Connecticut Department of Public Health, Hartford, Connecticut, USA., Ostrowsky B; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ham DC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Walters MS; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 19; Vol. 79 (1), pp. 6-14.

Chronic Obstructive Pulmonary Disease In Aboriginal Patients Of The Northern Territory Of Australia: A Landscape Perspective

Autor: Heraganahally SS, Wasgewatta SL, McNamara K, Eisemberg CC, Budd RC, Mehra S, Sajkov D

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 2205-2217 (2019)

Subash S Heraganahally,1–4 Sanjiwika L Wasgewatta,1 Kelly McNamara,2,3 Carla C Eisemberg,5 Richard C Budd,1 Sumit Mehra,1,3,6,6 Dimitar Sajkov2,6,7 1Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, NT, Australia; 2Flinders University

Externí odkaz: https://doaj.org/article/9cbfbe5eec8c4a33b9e5f59a16adb8b0